Rajendra Singh Garbyal

Rajendra Singh Garbyal serves as a Clinical Associate Professor at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research primarily focuses on oncology with particular expertise in neuroendocrine tumors, cancer diagnostics, and pathology. His work spans multiple disciplines including gastrointestinal oncology, pancreatic cancer, and molecular diagnostics.

Dr. Garbyal's research interests center on neuroendocrine tumor biology, classification, and treatment. His work explores biomarker discovery, surgical outcomes, and therapeutic responses in patients with various neuroendocrine neoplasms. He has made significant contributions to understanding tumor classification systems, recurrence patterns, and survival analysis in gastrointestinal and pancreatic neuroendocrine tumors. His research bridges clinical practice with laboratory investigations, particularly in the areas of cytology and pathological diagnosis.

Analysis of Dr. Garbyal's publication history reveals a strong focus on neuroendocrine tumors, with particular emphasis on pancreatic, appendiceal, and small intestinal variants. His recent work (2022-2024) predominantly addresses tumor classification, surgical outcomes, and treatment responses, while earlier publications (2007-2011) show broader interests in general pathology, cytology, and diagnostic techniques. The research demonstrates a progression from foundational diagnostic pathology toward specialized oncology research, particularly in neuroendocrine tumor management.

Dr. Garbyal collaborates extensively with the Copenhagen Neuroendocrine Tumour Centre and works alongside leading researchers including Langer S.W., Kjaer A., Knigge U., and Andreassen M. His research network spans multiple departments at the University of Copenhagen, focusing on translational cancer research that connects laboratory findings with clinical applications in oncology.